In-Situ Gelling System based on Thiolated Gellan Gum as New Carrier for Nasal Administration of Dimenhydrinate

DOI:

https://doi.org/10.37285/ijpsn.2009.2.2.8

Authors

  • Hitendra Mahajan
  • Hannan Shaikh
  • Surendra Gattani
  • Pankaj Nerkar

Abstract

The purpose of the present study was to develop intranasal delivery system of dimenhydrinate using thiolated gellan gum and formulations were modulated so as to have gelation at physiological ion content after intranasal administration.  Gelation was determined by physical appearance.  The mucoadhesive force in terms of detachment stress, determined using sheep nasal mucosa, increased with increasing concentration of thiolated polymer. The results of in vitro drug permeation studies across sheep nasal mucosa indicate that effective permeation could be significantly increased by using in situ gelling formulation with thiolated polymer concentration.  Finally, histopathological examination did not detect any changes during in vitro permeation studies.  In conclusion the gel formulation of dimenhydrinate with in situ gelling and mucoadhesive properties with increased permeation rate is promising for prolonging nasal residence time and thereby nasal absorption.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Thiolated gellan gum, in situ gel, Dimenhydrinate, Mucoadhesion, Nasal

Downloads

Published

2009-08-31

How to Cite

1.
Mahajan H, Shaikh H, Gattani S, Nerkar P. In-Situ Gelling System based on Thiolated Gellan Gum as New Carrier for Nasal Administration of Dimenhydrinate. Scopus Indexed [Internet]. 2009 Aug. 31 [cited 2024 Nov. 19];2(2):544-50. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/461

Issue

Vol. 2 No. 2 (2009): July-September 2009

Section

Research Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Alexander HK, Davide G, Andreas BS.Thiolated chitosan microparticle: A vehicle for nasal peptide drug delivery. Int J Pharm, 307:270-277 (2006).

Alexander HK, Verena ML, Andreas BS. Improvement in the In situ gelling properties of deaaetylated Gellan gum by Immobilization of Thiol groups. Wily InterScience.1234-1240 (2002).

Andreas BS, Margit H, Theresa Z. Thiolated polymers—thiomers: synthesis and in vitro evaluation of chitosan–2-iminothiolane conjugates. International Journal of Pharmaceutics. 260 :229–237 (2003).

Balasubramanyam J, Kant S, Pandit JK. In vitro and in vivo evaluation of the Gelrite® gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 53: 251–261 (2003).

Drug Facts and Comparisons. St. Louis, Mussouri,pocket version, eight edition,524.

Illum L, Watts L, Peter J.Composition for nasal administration US Patent 6,342,251. (2000).

Illum L. Nasal drug delivery—possibilities, problems and solutions. J Controlled Rel. 87:187–198 (2003).

Leitner VM, Walker G, Bernkop SA. Thiolated polymers: evidence for formation of disulfide bond with mucous glycoproteins. Eur. J. Pharm. Biopharm.56:207-214. (2003).

Murthy RSR , Majithiya RJ, Ghosh PK. Thermoreversible-mucoadhesive gel for nasal delivery of Sumatriptan. AAPS PharmSciTech. 7(3): E1- E7 (2006).

Rita JM, Pradip KG, Manish L U, Rayasa S RM, Thermo reversible mucoadhesive gel for nasal delivery of sumatriptan. AAPS pharmSciTech.7(3):E1-E7 (2006).

Yong CS, Choi JS, Rhee JD. Effect of sodium chloride on the gelation, gel strength, and Bioadhesive force of poloxamer gels. Int J Pharm.275: 195-205 (2001).

Zaki NM, Awada GA, Mortadaa ND. Enhanced bioavailability of metoclopramide HcL by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci.32: 296–307(2007).